sub:assertion { d:DB08977v:identifier "DB08977" ; v:namespace "drugbank" ; v:uri "http://bio2rdf.org/drugbank:DB08977" ; v:x-identifiers.org <http://identifiers.org/drugbank/DB08977> ; dv:drugbank-id "DB08977" ; dv:x-cas <http://bio2rdf.org/cas:9001-90-5> ; dv:x-wikipedia <http://bio2rdf.org/wikipedia:Fibrinolysin> ; dct:description "Fibrinolysin (also known as Plasmin) is a bovine enzyme derived from bovine plasma or extracted from bacterial cultures. It is a globular protein with a molecular weight of ~90,000 daltons. Fibrinolysin consists of two polypeptide chains, one light and one heavy, linked by a disulfide bond. The light chain has a molecular weight of approximately 27,000 Da and contains the active center of fibrinolysin; the heavy chain has a molecular weight of approximately 57,000 Da. Fibrolysin is used as a local healing ointment when combined together with the enzyme deoxyribonuclease I (extracted from bovine pancreas). Fibrinolysin and deoxyribonuclease both act as lytic enzymes. The combination is available as ointment containing 1 BU (Biological Unit) fibrinolysin and 666 BUs desoxyribonuclease per gram. The ointment is marketed by Pfizer under the brand name Fibrolan in a variety of countries is currently not approved in the USA."@en ; dct:identifier "drugbank:DB08977" ; dct:title "Fibrinolysin"@en ; adv:Drug ; rdfs:label "Fibrinolysin [drugbank:DB08977]"@en ; rdfs:seeAlso <http://www.drugbank.ca/drugs/DB08977> . }